NCT05298696View on ClinicalTrials.gov

Efficacy of Cilostazol in Prevention of Peripheral Neuropathy

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

71

Participants

Timeline

Start Date

March 28, 2022

Primary Completion Date

October 30, 2022

Study Completion Date

December 30, 2022

Conditions

Peripheral NeuropathyBreast Cancer

Interventions

DRUG

Cilostazol

Cilostazol 100 mg twice daily

DRUG

Placebo

Placebo twice daily

Trial Locations (1)

35516

Mansoura University, Al Mansurah

All Listed Sponsors

lead

Mansoura University

OTHER